StockNews.com initiated coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities research analysts have also issued reports on SGEN. Raymond James lowered shares of Seagen from a strong-buy rating […]
StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Get Rating) in a report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other analysts have also issued reports on the company. Barclays raised their price target on Seagen from $145.00 to $228.00 and gave the […]
StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Get Rating) in a report released on Monday. The firm issued a hold rating on the biotechnology company’s stock. SGEN has been the topic of a number of other reports. Guggenheim reiterated a buy rating and issued a $170.00 price objective on shares of Seagen in […]
JPMorgan Chase & Co. increased its stake in Seagen Inc. (NASDAQ:SGEN – Get Rating) by 12.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,272,789 shares of the biotechnology company’s stock after acquiring an additional 363,133 shares during the quarter. JPMorgan Chase & […]
Simplify Asset Management Inc. bought a new stake in Seagen Inc. (NASDAQ:SGEN – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,566 shares of the biotechnology company’s stock, valued at approximately $201,000. Several other hedge funds have also recently made […]